Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
VRTX · against 1,372 other Healthcare companies
Ranked #384 of 1,373 · scores higher than 72% of peers · safety percentile 72
Bars: peers in each 10-point band of the safety percentile (higher = safer; 67+ earns the lower-risk grade)137 peers with a safety percentile of 70–79, including VRTX · Click a bar to see the companies
Mainly thanks to its debt / equity and beta, which are stronger than most Healthcare peers.
Risk is relative to the sector, not a bankruptcy probability. Banks and brokers carry high leverage by design, and share buybacks can shrink equity and current assets, which raises debt/equity on paper.
| Metric | VRTX | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Debt / equityLower is better · 1,280 reported | 0.10× | 0.24× | 67% | 33% | |
| BetaLower is better · 1,320 reported | 0.32 | 0.53 | 66% | 33% | |
| Current ratioHigher is better · 1,338 reported | 3.19× | 2.62× | 58% | 33% |
| Rank | Company | Market cap | Safety | Overall |
|---|---|---|---|---|
| 1 | 5.6B USD | 100 | 53 | |
| 1 | 6.6B USD | 100 | 45 | |
| 3 | 186M USD | 100 | 52 | |
| 4 | 1.5B USD | 100 | 44 | |
| 5 | 1.2B USD | 100 | 40 | |
| 380 | 7.2B CNY (≈$1.0B) | 72 | 62 | |
| 381 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score
| 609M USD |
| 72 |
| 91 |
| 382 | 10.0B CNY (≈$1.4B) | 72 | 58 |
| 383 | 287.6B KRW (≈$207M) | 72 |
| 384 | 134.5B USD | 72 | 70 |
| 385 | 3.1B CNY (≈$438M) | 72 | 46 |
| 386 | 1.9B CNY (≈$270M) | 72 | 44 |
| 387 | 4.7B CNY (≈$661M) | 72 | 26 |
| 388 | 6.8B HKD (≈$867M) | 72 | 56 |